The Vent Multiplexor is a patent-pending emergency co-ventilation device intended to provide individualized temporary rescue mechanical ventilation during the COVID-19 pandemic. Developed in collaboration with Yale-New Haven Hospital and granted Emergency Use Authorization by the FDA on April 15, 2020, the Vent Multiplexor has the potential to help reduce the clinical need for ventilators during the COVID-19 pandemic, as it permits the emergency sharing of ventilators between two patients who are not equally matched, by delivering individualized tidal volumes, while also providing critical validation data on the quality of patient matching using existing “T-connector” and similar ventilator splitting technologies, a potentially revolutionary paradigm shift in the delivery of pandemic emergency respiratory care.
BEACON VENT MULTIPLEXOR
The Beacon Vent Multiplexor is a robust ventilator support solution to assist hospital, healthcare providers, and patients at a time where critical care and knowledge are at a premium.
The Problem
The COVID-19 pandemic has created an unprecedented health and economic crisis like no other in recent history. With millions of confirmed cases worldwide, and millions more presumed to carry the virus, there is a significant and continuing risk that the number of critically ill patients requiring emergency ventilation will exceed available ventilator resources, particularly as countries around the world move towards reopening economies and as the flu season begins.
Our Solution
The enhanced monitoring capabilities of Mermaid's Beacon Care System bundled with Vent Multiplexors ventilator splitters is a practical and cost effective solution for hospitals and municipalities that are dealing with a surge of cases and finite resources - including managing limited ICU quality ventilators, restricted monitoring capabilities, and limited critical care staff.